read more

first_imgNews | January 23, 2013 Ablation Devices to Be the Fastest Growing Segment in the U.S. Nonvascular Interventional Radiology Device Market Overall market to grow moderately to $295 million by 2017, according to Millennium Research Group Image courtesy of NinePoint Medical News | Interventional Radiology | July 31, 2019 International Multidisciplinary Group Publishes Recommendations for Personalized HCC Treatment With Y90 TheraSphere New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s TheraSphere have… read more January 23, 2013 — According to Millennium Research Group (MRG), the segment of the U.S. nonvascular interventional radiology device market with the fastest growth and greatest potential is ablation devices, comprising radiofrequency (RF) ablation, cryoablation and microwave ablation devices. The overall market will grow moderately to $295 million by 2017.Ablation devices offer a minimally invasive alternative to traditional surgical treatment of liver, prostate, kidney and lung cancers, and this segment is growing quickly because of the increasing popularity of minimally invasive treatments and the rising incidence of these soft tissue cancers.RF ablation is the most established device type, but microwave ablation and cryoablation are growing rapidly, due to some advantages these types of ablation offer. Microwave ablation devices can produce larger ablation zones and don’t suffer as much from the heat sink effect that can handicap RF ablation. Growth in microwave ablation devices has stalled growth in RF ablation, and this segment of the market will slightly decline through 2017.Microwave ablation devices are currently sold mainly by smaller companies with limited distribution networks. This has made them attractive acquisition targets by more established companies. For example, AngioDynamics, a leader in RF ablation, recently made a large investment in Microsulis, a microwave ablation company.Cryoablation devices are the only kind of ablation device that can be used to treat prostate cancer. Urologists and interventional radiologists both use cryoablation to treat kidney cancer, using differing techniques.“Cryoablation is more versatile than other ablation devices because its effects do not need to be permanent,” said MRG Analyst Sean Messenger. “As a result, it can be useful in indications outside of cancer, most prominently in pain palliation, another growing market. Competitors see the opportunity for significant growth, leading Endo Health Solutions, a company with a large pain franchise and a focus on pain palliation, to acquire the top cryoablation manufacturer, HealthTronics, in 2010.”Millennium Research Group’s U.S. Markets for Nonvascular Interventional Radiology Devices 2013 report includes unit, installed base, average selling price and revenue information, along with market drivers and limiters and competitive landscape for ablation devices, percutaneous drainage catheters and soft tissue biopsy needles in the United States.For more information: www.MRG.net, www.DecisionResourcesGroup.com FacebookTwitterLinkedInPrint分享 VIDEO: How Alexa Might Help During Interventional Radiology ProceduresKevin Seals, M.D., is working on a research project using smart speakers such as the Amazon Echo and Google Home to create a new method for accessing information on device technologies in real time in the interventional radiology (IR) lab.Video Player is loading.Play VideoPlayMuteCurrent Time 0:00/Duration 4:47Loaded: 3.40%Stream Type LIVESeek to live, currently playing liveLIVERemaining Time -4:47 Playback Rate1xChaptersChaptersDescriptionsdescriptions off, selectedCaptionscaptions settings, opens captions settings dialogcaptions off, selectedAudio Trackdefault, selectedFullscreenThis is a modal window.Beginning of dialog window. Escape will cancel and close the window.TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaqueFont Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall CapsReset restore all settings to the default valuesDoneClose Modal DialogEnd of dialog window.Close Modal DialogThis is a modal window. This modal can be closed by pressing the Escape key or activating the close button. Technology | Interventional Radiology | June 24, 2019 Mentice and Siemens Healthineers Integrate VIST Virtual Patient With Artis Icono Angiography System Siemens Healthineers and Mentice AB announced the collaboration to fully integrate Mentice’s VIST Virtual Patient into… read more Related Content Technology | Information Technology | June 20, 2019 DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet… read more News | Interventional Radiology | July 03, 2019 Varian Purchasing Embolic Bead Assets from Boston Scientific Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable… read more center_img Henry Ford Hospital’s ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology. Videos | Interventional Radiology | June 26, 2019 VIDEO: How Alexa Might Help During Interventional Radiology Procedures Kevin Seals, M.D.,… read more Technology | Interventional Radiology | August 14, 2019 FDA Clears NvisionVLE Imaging System for Pancreatic and Biliary Applications August 14, 2019 — NinePoint Medical Inc. announced it has received U.S. read more News | CT Angiography (CTA) | July 24, 2019 WVU Medicine Installs First Alphenix 4D CT in the U.S. The West Virginia University (WVU) Heart and Vascular Institute is the first hospital in the country to acquire the… read more News | Interventional Radiology | June 19, 2019 Merit Medical Acquires Brightwater Medical Inc. Merit Medical Systems Inc. announced it has acquired Brightwater Medical Inc., based in Temecula, Calif. Brightwater… read more Technology | Interventional Radiology | August 16, 2019 Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to… read more Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor Innovations in Radiotherapy and Radiology at Henry Ford Hospital Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res read morelast_img

Leave a Reply

Your email address will not be published. Required fields are marked *